Grant: CIHR Fellowship
University of Calgary
$90,000.00
Genetic and epigenetic dysregulation caused by transposable elements in pediatric high-grade gliomas.
FY 2019-20
Summary
Pediatric high-grade gliomas (pHGGs) are lethal brain tumours with no effective therapies. In most cases, the source of genetic damage leading to tumour formation remains unknown. One potential cause of pediatric DNA damage is specialized DNA sequences that can 'transpose' or move to different positions in the genome. Unlike most DNA, transposable elements (TEs) can mobilize by cutting or copying themselves and then reinserting elsewhere in the genome. Each TE reinsertion event may disturb the sequence or regulation of nearby genes. Although there are millions of TEs in the human genome, the vast majority cannot move around due to errors in reinsertion or DNA damage. Hundreds of TEs, however, remain capable of mobilization. TE mobility is normally prevented by various cellular defense mechanisms to limit further DNA damage, however, these defense mechanisms are weakened or disabled at specific times during development, allowing TEs an opportunity to cause damage.
Considering that TEs mobilize more frequently in the brain than other tissues, we hypothesise that TEs could be a significant contributor to cancer-promoting genetic mutations in pHGG. We therefore propose to analyze TEs in pHGG by multiple molecular sequencing approaches: Whole genome sequencing to identify TE insertion sites, ATAC sequencing to identify open regions of DNA, RNA sequencing to measure gene expression, and proteomics to measure protein levels.
Together, these approaches will allow us to identify genomic changes caused by TEs and their effects on gene regulation. Defining these genetic events will allow the development of targeted therapeutics or genetic screening approaches to identify individuals with increased risk of disease development. Additionally, this work could be extended to other pediatric brain tumour types with potentially similar developmental origins and elevated levels of TE mobilization.
Department
Program
CIHR Fellowship
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
412366
Name
Johnston Michael J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Genetic and epigenetic dysregulation caused by transposable elements in pediatric high-grade gliomas.
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioinformatics; Brain Development; Dna Damage; Epigenetics; Glioma; Nanopore Sequencing; Pediatric Tumours; Single-Cell Sequencing; Transposable Elements; Whole Genome Sequencing
Abstract
Pediatric high-grade gliomas (pHGGs) are lethal brain tumours with no effective therapies. In most cases, the source of genetic damage leading to tumour formation remains unknown. One potential cause of pediatric DNA damage is specialized DNA sequences that can 'transpose' or move to different positions in the genome. Unlike most DNA, transposable elements (TEs) can mobilize by cutting or copying themselves and then reinserting elsewhere in the genome. Each TE reinsertion event may disturb the sequence or regulation of nearby genes. Although there are millions of TEs in the human genome, the vast majority cannot move around due to errors in reinsertion or DNA damage. Hundreds of TEs, however, remain capable of mobilization. TE mobility is normally prevented by various cellular defense mechanisms to limit further DNA damage, however, these defense mechanisms are weakened or disabled at specific times during development, allowing TEs an opportunity to cause damage.
Considering that TEs mobilize more frequently in the brain than other tissues, we hypothesise that TEs could be a significant contributor to cancer-promoting genetic mutations in pHGG. We therefore propose to analyze TEs in pHGG by multiple molecular sequencing approaches: Whole genome sequencing to identify TE insertion sites, ATAC sequencing to identify open regions of DNA, RNA sequencing to measure gene expression, and proteomics to measure protein levels.
Together, these approaches will allow us to identify genomic changes caused by TEs and their effects on gene regulation. Defining these genetic events will allow the development of targeted therapeutics or genetic screening approaches to identify individuals with increased risk of disease development. Additionally, this work could be extended to other pediatric brain tumour types with potentially similar developmental origins and elevated levels of TE mobilization.
Competitiondate
201910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Johnston, Michael J
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~